Stock Comparison
BMY vs JNJ
Bristol-Myers Squibb Company and Johnson & Johnson side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$117.46B
$613.02B
P/E (TTM)
16.1
29.5
Forward P/E
8.8
22.0
Price/Sales
2.4
6.4
Price/Book
5.6
7.6
EV/EBITDA
9.9
19.2
Dividend Yield
4.51%
2.12%
Profitability
Net Margin
15.00%
21.80%
Operating Margin
33.00%
27.40%
Return on Equity
38.70%
26.40%
Return on Assets
10.70%
8.42%
Growth (YoY)
Revenue Growth
2.60%
9.90%
Earnings Growth
9.20%
-52.90%
Price & Risk
Beta
0.2
0.3
52-Week High
$62.25
$255.11
52-Week Low
$41.46
$147.81
Analyst Target
$63.08
$257.32
Compare BMY and JNJ your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.